This is consistent with previous data suggesting that K-ras amplification could be an early event in the pathogenesis of prostatic carcinogenesis (Lau et al. 2004) and may be a critical factor that drives prostate cancer development (Weber and Gioeli 2004). This evidence concerns the gene KRAS and Familial prostate cancer.